Viewing Study NCT00911066


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-27 @ 12:24 AM
Study NCT ID: NCT00911066
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2009-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module